Fermenta Biotech Ltd.
BSE: FERMENTA
Prev Close
332.4
Open Price
339.95
Volume
18,203
Today Low / High
330.05 / 342.75
52 WK Low / High
240 / 399
Range
322 - 356
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 339.3, reflecting a change of 6.9 (2.07581%). The expected target range on the BSE is 322 - 356. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Fermenta Biotech Ltd. Graph
Fermenta Biotech Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Fermenta Biotech Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 339.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 339.30 | 342.69 | 308.42 - 376.96 |
| 346.09 | 276.87 - 415.30 | ||
| 349.48 | 244.64 - 454.32 | ||
| Bearish Scenario | 339.30 | 335.91 | 302.32 - 369.50 |
| 332.51 | 266.01 - 399.02 | ||
| 329.12 | 230.38 - 427.86 |
Overview of Fermenta Biotech Ltd.
ISIN
INE225B01021
Industry
Biotechnology
Vol.Avg
29,534
Market Cap
9,388,489,000
Last Dividend
2.5
Official Website
IPO Date
2024-12-30
DCF Diff
-375.01
DCF
694
Financial Ratios Every Investor Needs
Stock Dividend of FERMENTA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-06 | August 06, 25 | 2.5 | 2.5 | 2025-08-06 | 2025-08-22 | |
| 2024-08-06 | August 06, 24 | 1.25 | 1.25 | 2024-08-06 | 2024-08-22 | |
| 2023-09-22 | September 22, 23 | 1.25 | 1.25 | 2023-09-22 | 2023-10-10 | |
| 2022-08-04 | August 04, 22 | 1.25 | 1.25 | 2022-08-05 | 2022-08-22 | |
| 2021-08-25 | August 25, 21 | 2.5 | 2.5 | 2021-08-26 | 2021-09-13 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 469.48 Cr | 147.40 Cr | 322.08 Cr | 0.6860 | 12.02 Cr | 14.91 Cr | 85.58 Cr | 76.86 Cr | 26.47 | 121.62 Cr | 0.1637 |
| 2024-03-31 | 333.46 Cr | 153.45 Cr | 68.12 Cr | 0.2043 | 13.34 Cr | 59.44 Cr | 3.76 Cr | -23.06 Cr | -7.99 | 30.79 Cr | -0.0692 |
| 2023-03-31 | 349.32 Cr | 287.98 Cr | 61.34 Cr | 0.1756 | 13.39 Cr | 15.65 Cr | -7.09 Cr | -51.08 Cr | -17.70 | -1.69 Cr | -0.1462 |
| 2022-03-31 | 398.16 Cr | 298.67 Cr | 99.49 Cr | 0.2499 | 8.19 Cr | 48.95 Cr | 36.86 Cr | 15.45 Cr | 5.35 | 70.48 Cr | 0.0388 |
| 2021-03-31 | 371.65 Cr | 143.68 Cr | 113.75 Cr | 0.3061 | 5.60 Cr | 43.36 Cr | 167.12 Cr | 45.51 Cr | 15.77 | 87.61 Cr | 0.1224 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 28.24 Cr | 614.48 Cr | 255.96 Cr | 362.6722 Cr | 114.94 Cr | 86.70 Cr | 123.65 Cr | 232.16 Cr | 0.00 Cr | 0.16 Cr | 4.13 Cr | 211.8760 Cr |
| 2024-03-31 | 21.83 Cr | 547.83 Cr | 262.67 Cr | 288.8610 Cr | 138.77 Cr | 116.94 Cr | 89.07 Cr | 253.47 Cr | 1.59 Cr | 18.47 Cr | 0.44 Cr | 173.2607 Cr |
| 2023-03-31 | 35.29 Cr | 636.52 Cr | 323.95 Cr | 315.3138 Cr | 219.52 Cr | 184.23 Cr | 131.16 Cr | 258.47 Cr | 0.00 Cr | 8.94 Cr | 0.38 Cr | 208.7184 Cr |
| 2022-03-31 | 20.97 Cr | 706.84 Cr | 335.39 Cr | 372.1347 Cr | 239.18 Cr | 218.21 Cr | 173.32 Cr | 237.33 Cr | 0.00 Cr | 0.24 Cr | 73.29 Cr | 207.1234 Cr |
| 2021-03-31 | 27.05 Cr | 707.49 Cr | 347.19 Cr | 360.5902 Cr | 232.19 Cr | 205.13 Cr | 170.86 Cr | 222.59 Cr | 0.00 Cr | 0.34 Cr | 69.16 Cr | 209.3335 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 40.9020 Cr | -0.1595 Cr | -50.8658 Cr | 18.7688 Cr | -10.1234 Cr | 6.6279 Cr | -22.1332 Cr | 83.2078 Cr | -35.8243 Cr | -3.6118 Cr | -36.2671 Cr |
| 2024-03-31 | 105.3459 Cr | -15.4974 Cr | -90.8518 Cr | 86.1388 Cr | -1.0033 Cr | 16.7513 Cr | -19.2071 Cr | -23.0598 Cr | -69.2345 Cr | -3.6093 Cr | 42.7556 Cr |
| 2023-03-31 | 116.1083 Cr | -55.4085 Cr | -41.3799 Cr | 75.6189 Cr | 19.3688 Cr | 17.7546 Cr | -40.4894 Cr | -51.0752 Cr | -18.9282 Cr | -4.1997 Cr | 9.9313 Cr |
| 2022-03-31 | 43.4412 Cr | -26.0376 Cr | -21.5784 Cr | 6.3130 Cr | -4.1748 Cr | -1.8835 Cr | -37.1282 Cr | 15.4471 Cr | 3.6718 Cr | -7.2118 Cr | 2.7940 Cr |
| 2021-03-31 | 62.5972 Cr | -41.5498 Cr | -1.1432 Cr | 7.3263 Cr | 20.5157 Cr | 2.2913 Cr | -55.2709 Cr | 45.5066 Cr | 17.7450 Cr | 0.0000 Cr | -19.1660 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 137.36 Cr | 77.76 Cr | 59.60 Cr | 0.4339 | 19.59 Cr | 12.68 Cr | 4.36 | 25.89 Cr | 0.0923 |
| 2025-09-30 | 130.22 Cr | 46.56 Cr | 83.66 Cr | 0.6425 | 21.23 Cr | 18.88 Cr | 6.48 | 32.07 Cr | 0.1450 |
| 2025-06-30 | 136.26 Cr | 47.04 Cr | 89.22 Cr | 0.6548 | 22.42 Cr | 21.83 Cr | 7.49 | 37.00 Cr | 0.1602 |
| 2025-03-31 | 139.85 Cr | 50.13 Cr | 89.71 Cr | 0.6415 | 31.08 Cr | 34.39 Cr | 11.84 | 40.84 Cr | 0.2459 |
| 2024-12-31 | 156.47 Cr | 42.20 Cr | 114.27 Cr | 0.7303 | 47.19 Cr | 36.91 Cr | 12.71 | 55.50 Cr | 0.2359 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 25.92 Cr | 27.73 Cr | 53.65 Cr | 119.50 Cr | 139.36 Cr | 336.04 Cr | 235.38 Cr | 651.40 Cr | 265.88 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 70.66 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -358.52 Cr |
| 2025-03-31 | 28.24 Cr | 42.42 Cr | 87.08 Cr | 105.18 Cr | 123.65 Cr | 335.23 Cr | 232.16 Cr | 614.48 Cr | 255.96 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 36.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -286.02 Cr |
| 2024-09-30 | 20.63 Cr | 16.82 Cr | 37.45 Cr | 80.53 Cr | 101.35 Cr | 244.45 Cr | 250.14 Cr | 539.32 Cr | 253.29 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 21.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 34.39 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 36.91 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 11.38 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -5.82 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2020-02-13 | February 13, 20 | 3:1 |
| 2018-08-08 | August 08, 18 | 4:1 |
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹395.80 | ₹502,336,973,043.00 | ₹3,554,697.00 |
| Anthem Biosciences Ltd. | ANTHEM | ₹670.15 | ₹376,432,537,248.00 | ₹141,357.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹155.37 | ₹205,611,590,763.00 | ₹1,450,331.00 |
| Onesource Specialty Pharma Ltd. | ONESOURCE | ₹1,473.90 | ₹168,940,186,680.00 | ₹277,137.00 |
| Syngene International Limited | SYNGENE | ₹409.30 | ₹164,437,005,191.00 | ₹675,182.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,197.20 | ₹125,246,519,429.00 | ₹100,555.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹570.75 | ₹90,184,712,614.00 | ₹363,355.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹376.10 | ₹65,240,346,343.00 | ₹357,325.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹604.80 | ₹48,675,997,440.00 | ₹105,837.00 |
| Zota Health Care Limited | ZOTA | ₹1,176.70 | ₹35,692,435,139.00 | ₹47,409.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹164.51 | ₹25,792,386,958.00 | ₹431,232.00 |
Key Executives
Gender: male
Year Born: 1980
Gender: male
Year Born:
Gender: male
Year Born: 1971
Gender: male
Year Born:
Gender: male
Year Born: 1970
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born: 1979
Gender: male
Year Born:
Gender: male
Year Born:
FAQs about Fermenta Biotech Ltd.
The CEO is Prashant Prabhakar Nagre.
The current price is ₹319.00.
The range is ₹225-399.
The market capitalization is ₹938.85 crores.
The dividend yield is 0.78%.
The P/E ratio is 10.57.
The company operates in the Healthcare sector.
Overview of Fermenta Biotech Ltd. (ISIN: INE225B01021) is a leading Biotechnology in India. With a market capitalization of ₹938.85 crores and an average daily volume of 29,534 shares, it operates in the Biotechnology. The company last declared a dividend of ₹2.5.